All the sessions of the event will be recorded and the recordings will be available through the Indico and HITRIplus web page and youtube channel. Additionally, pictures will be taken each day of the event.
Therefore, people that do not wish to appear in the recording or the photos are invited to contact the organisers; online participants may wish to switch off their cameras.
The agenda includes the scientific sessions and topics listed below: the detailed timetable including speakers and their titles in a PDF format can be found HERE
The timetable, presentations and recordings will be available in indico
Friday 18th October 2024
GENERAL INTRODUCTION: set the stage
Moderators: Manjit Dosanjh
SESSION 1 – HADRON THERAPY OVERVIEW
|
Time |
Tittle |
|
08:30 - 08:45 |
Participants registration |
|
08:45 - 09:15 |
Welcome Addresses Maria Bigaki (IAEA CP, Papageorgiou), Sotirios Charisopoulos (IAEA), |
|
09:15 - 09:35 |
Historic and scientific evolution of Hadron Therapy Ugo Amaldi (TERA) and Sandro Rossi (CNAO) |
|
09:35 – 09:55 |
Hadron Therapy in clinical practice Ester Orlandi (CNAO, Uni Pavia) |
|
09:55 – 10:15 |
Radiobiology of Hadron Therapy Angelica Facoetti (CNAO) |
|
10:15 – 10:35 |
HITRIplus project, its impact on boosting research in South East Europe and future perspectives Sanja Damjanovic (GSI)
|
|
10:35 – 10:55 |
Socio-economic benefits of accelerator based Hadron Therapy facilities Sotirios Charichopoulos (IAEA) |
|
10:55 – 11:30 |
Coffee Break |
SESSION 2 – HADRON THERAPY DEVELOPMENTS AND FUTURE PERSPECTIVES
Moderators: Roberto Orecchia
|
Time |
Tittle |
|
11:30 - 11:50 |
Hadron Therapy : from pioneering times towards the future Manjit Dosanjh (Uni Oxford) |
|
11:50 - 12:10 |
SEEIIST facility design and alternatives Maurizio Vretenar (CERN) |
|
12:10 - 12:30 |
CERN as an example of large scale infrastructure Emmanuel Tsesmelis (CERN) |
|
12:30 – 12:50 |
Status and vision of the SEEIIST project Leandar Litov (Uni Sofia) |
|
12:50 – 13:30 |
Round table – SEEIIST towards to the Future Introduction: cancer incidence in SEE, Mimoza Ristova (Uni Skopje) |
|
13:30 – 13:45 |
Concluding remarks Roberto Orecchia |
|
13:45 – 15:00 |
Lunch Break |
SESSION 3 – EXPERIENCES OF MULTIPARTICLE THERAPY FACILITIES IN OPERATION IN EUROPE
Moderators:
|
Time |
Tittle |
|
15:00 - 15:20 |
Hadron Therapy at GSI - where we come from, where we go Konrad Lehmann (GSI) |
|
15:20 - 15:40 |
The HIT facility, technology, clinical applications and research: novel approaches in particle therapy Andrea Mairani (HIT) |
|
15:40 - 16:00 |
The Marburg facility Klemens Zink (MIT) |
|
16:00 – 16:20 |
The Krakow Hadron Therapy facility, lessons learnt Pawel Olko (IFJPAN) |
|
16:20 – 16:40 |
Role of imaging George Dedes (LMU) |
|
16:40 – 17:00 |
Coffee Break |
SESSION 4 – ADVANCES IN ACCELERATOR TECHNOLOGIES FOR HADRON THERAPY FACILITIES
Moderators: Laura Vallow
|
Time |
Tittle |
|
17:00 - 17:20 |
Accelerator developments for medical and societal applications Yiannis Papaphilippou (CERN) |
|
17:20 - 17:35 |
Optimisation for pre-injectors for hadron therapy Aris Mamaras (CERN/AUTH) |
|
17:35 – 17:50 |
Optimisation of double use linac injector for hadron therapy facilities TBC |
|
17:50 – 18:05 |
An ion source project as a seed to boost development of accelerator technologies in Bosnia-and-Herzegovina TBC |
|
18:05 – 18:20 |
Development of the first table-top X-ray FLASH system Elpida Theodoridou (DKFZ, Uni Malta), Joao Seco (DKFZ, Uni Heidelberg) |
|
18:20 – 18:30 |
Concluding remarks Laura Vallow |
|
20:30 |
Welcome addresses by political and other authorities Concert and Welcome Drink |
SPECIFIC SESSIONS: Hadron Therapy Indications
Saturday 19 October 2024
SESSION 5 – INDICATIONS FOR HADRON THERAPY
Moderators: Arnold Pompos, Joao Seco
|
Time |
Tittle |
|
09:00 - 09:20 |
Indications and clinical applications of HT at the Marburg facility Fabian Eberle (MIT) |
|
09:20 – 09:40 |
Chordoma treatments at CNAO Maria Rosaria Fiore (CNAO) |
|
09:40 – 10:00 |
Sarcoma treatments in Greece TBC |
|
10:00 – 10:20 |
Modern radiation therapy techniques for head-and-neck cancer Petros Alexidis (PAPAGEORGIOU) |
|
10:20 – 10:40 |
Proton versus photon radiation therapy: advantages and disadvantages Efstathios Kamperis (PAPAGEORGIOU) |
|
10:40 – 11:00 |
Personalization of Hadron Therapy for H&N cancers: Patient Triage Based upon Bioindicators of Radioresistance Michael D. Story (Mayo Clinic) |
|
11:00 – 11:05 |
Concluding remarks Arnold Pompos, Joao Seco |
|
11:05 – 11:30 |
Coffee Break |
SESSION 6 – SOCIO-ECONOMIC ASPECTS RELATED TO HADRON THERAPY
Moderators: Sandro Rossi
|
Time |
Tittle |
|
11:30 - 11:50 |
Tools to support the EU networking on hadron therapy Lisa Licitra (CNAO, Uni Milan) |
|
11:50 – 12:10 |
Hadron therapy cost-benefit analysis applied to operations in CNAO Maria Vittoria Livraga (CNAO) |
|
12:10 – 12:30 |
Caring for cancer patients: the CNAO social approach Silvia Meneghello (CNAO) |
|
12:30 – 12:45 |
Citizen and Patient Science Stefania Oikonomou (Web2Learn) |
|
12:45 – 13:00 |
Empowering patient advocacy and cancer prevention Panagiotis Bamidis (AUTH/AHEPA) |
|
13:00 - 13:10 |
The role of biomedical and clinical engineering societies in advancing and promoting Hadron Therapy on a national and international level Alkinoos Athanasiou (AUTH, ELEVIT) |
|
13:10 – 13:30 |
Hadron Therapy in Greece EOPPY Delegate TBC |
|
13:30 – 13:35 |
Concluding remarks Sandro Rossi |
|
13:35 – 15:00 |
Lunch Break |
SESSION 7 – PEDIATRIC ONCOLOGY AND ROLE OF HADRON THERAPY
Moderators: Antonio Capizzello, Emmanouel Chatzipantelis, Papakonstantinou Eugenia, Semi Harrabi
|
Time |
Tittle |
|
15:00 - 15:20 |
Hadron therapy state-of-the art in pediatric oncology-clinical aspects Sabina Vennarini (CNAO) |
|
15:20 - 15:40 |
Treatment planning for pediatric cancer tumour treatments Silvia Molinelli (CNAO) |
|
15:40 - 16:00 |
Pediatric patients referred for hadron therapy Barbara Rombi (TRENTO) |
|
16:00 -16:20 |
Pediatric patients commonly referred for Radiotherapy Capizzello Antonio (AUTH / AHEPA) |
|
16:20 – 16:50 |
Coffee Break |
|
16:50 – 18:20 |
Panel discussion: Paediatric Oncology in Greece Emmanouel Chatzipantelis (AHEPA), Eugenia Papakonstantinou (IPPOKRATEION) Nikos Foroglou (AHEPA), Christos Stefanidis (IPPOKRATEION), George Giakoumetis (AHEPA) |
|
18:20 – 18:30 |
Concluding remarks Semi Harrabi |
